Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'VENLAFAXINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 273 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bae, JH; Moon, DG; Lee, JG
      The effects of a selective noradrenaline reuptake inhibitor on the urethra: an in vitro and in vivo study

      BJU INTERNATIONAL
    2. Post, RM; Altshuler, LL; Frye, MA; Suppes, T; Rush, AJ; Keck, PE; McElroy, SL; Denicoff, KD; Leverich, GS; Kupka, R; Nolen, WA
      Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers

      BIPOLAR DISORDERS
    3. Tournel, G; Houdret, N; Hedouin, V; Deveaux, M; Gosset, D; Lhermitte, M
      High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum

      JOURNAL OF CHROMATOGRAPHY B
    4. Matoga, M; Pehourcq, F; Titier, K; Dumora, F; Jarry, C
      Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma - Application to management of acute intoxications

      JOURNAL OF CHROMATOGRAPHY B
    5. Dorz, S; Cognolato, S; Conforti, D; Scarso, C; Borgherini, G
      A naturalistic study on the criteria of choice of second-generation antidepressants: A comparison of venlafaxine and SSRIs in depressed inpatients

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    6. Stein, DJ; Kasper, S; Matsunaga, H; Osser, DN; Stein, MB; Van Ameringen, M; Versiani, M; Westenberg, H; Zhang, MY
      Pharmacotherapy of social anxiety disorder: an algorithm for primary care-2001

      PRIMARY CARE PSYCHIATRY
    7. Pandit, SA; Argyropoulos, S; Nutt, DJ
      Current status of anxiolytic drugs

      PRIMARY CARE PSYCHIATRY
    8. Lynch, ME
      Antidepressants as analgesics: a review of randomized controlled trials

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    9. Wellington, K; Perry, CM
      Venlafaxine extended-release - A review of its use in the management of major depression

      CNS DRUGS
    10. Nierenberg, AA
      Current perspectives on the diagnosis and treatment of major depressive disorder

      AMERICAN JOURNAL OF MANAGED CARE
    11. Ninan, PT
      Recent perspectives on the diagnosis and treatment of generalized anxiety disorder

      AMERICAN JOURNAL OF MANAGED CARE
    12. Thase, ME
      The clinical, psychosocial, and pharmacoeconomic ramifications of remission

      AMERICAN JOURNAL OF MANAGED CARE
    13. Patel, NC; Crismon, ML; Rush, AJ; Frances, A
      Practitioner versus medication-expert opinion on psychiatric pharmacotherapy of mentally retarded patients with mental disorders

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    14. McDaniel, WW
      Serotonin syndrome: Early management with cyproheptadine

      ANNALS OF PHARMACOTHERAPY
    15. Sumpton, JE; Moulin, DE
      Treatment of neuropathic pain with venlafaxine

      ANNALS OF PHARMACOTHERAPY
    16. Smith, DF; Hansen, SB; Ostergaard, L; Gee, AD; Danielsen, E; Ishizu, K; Bender, D; Poulsen, PH; Gjedde, A
      [C-14]serotonin uptake and [O-methyl-C-11]venlafaxine kinetics in porcine brain

      NUCLEAR MEDICINE AND BIOLOGY
    17. Turcotte, JE; Debonnel, G; de Montigny, C; Hebert, C; Blier, P
      Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects

      NEUROPSYCHOPHARMACOLOGY
    18. Judd, FK; Piterman, L; Cockram, AM; McCall, L; Weissman, MM
      A comparative study of venlafaxine with a focused education and psychotherapy program versus venlafaxine alone in the treatment of depression in general practice

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    19. Miller, FE
      Strategies for the rapid treatment of depression

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    20. Blier, P; Haddjeri, N; Szabo, ST; Dong, JM
      Enhancement of serotoninergic function - A sometimes insufficient cause ofantidepressant action

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    21. Kennedy, SH; Eisfeld, BS; Meyer, JH; Bagby, RM
      Antidepressants in clinical practice: Limitations of assessment methods and drug response

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    22. Jaunay, E; Gaillac, V; Guelfi, JD
      The serotonin syndrome: what treatment and when

      PRESSE MEDICALE
    23. Jacobs, ES; Dickstein, DP; Liebelt, EL
      Novel psychotropic medications in children: New toxicities to master

      PEDIATRIC EMERGENCY CARE
    24. Rivas-Vazquez, RA
      Antidepressants as first-line agents in the current pharmacotherapy of anxiety disorders

      PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE
    25. Goeringer, KE; McIntyre, IM; Drummer, OH
      Postmortem tissue concentrations of venlafaxine

      FORENSIC SCIENCE INTERNATIONAL
    26. Wikell, C; Kugelberg, FC; Hjorth, S; Apelqvist, G; Bengtsson, F
      Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy

      CLINICAL NEUROPHARMACOLOGY
    27. Hilleret, H; Jeunet, E; Osiek, C; Mohr, S; Blois, R; Bertschy, G
      Mania resulting from continuous positive airways pressure in a depressed man with sleep apnea syndrome

      NEUROPSYCHOBIOLOGY
    28. Hellerstein, DJ; Batchelder, S; Kreditor, D; Fedak, M
      Bupropion sustained-release for the treatment of dysthymic disorder: An open-label study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    29. Haddad, PM; Devarajan, S; Dursun, SM
      Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'

      JOURNAL OF PSYCHOPHARMACOLOGY
    30. Melichar, JK; Haida, A; Rhodes, C; Reynolds, AH; Nutt, DJ; Malizia, AL
      Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers

      JOURNAL OF PSYCHOPHARMACOLOGY
    31. Hebert, C; Habimana, A; Elie, R; Reader, TA
      Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study

      NEUROCHEMISTRY INTERNATIONAL
    32. Brawman-Mintzer, O
      Pharmacologic treatment of generalized anxiety disorder

      PSYCHIATRIC CLINICS OF NORTH AMERICA
    33. Cherkaoui, S; Rudaz, S; Veuthey, JL
      Nonaqueous capillary electrophoresis-mass spectrometry for separation of venlafaxine and its phase I metabolites

      ELECTROPHORESIS
    34. Manier, DH; Shelton, RC; Sulser, F
      Cross-talk between PKA and PKC in human fibroblasts: what are the pharmacotherapeutic implications?

      JOURNAL OF AFFECTIVE DISORDERS
    35. Bickeboeller-Friedrich, J; Maurer, HH
      Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes

      THERAPEUTIC DRUG MONITORING
    36. Quitkin, FM; Taylor, BP; Kremer, C
      Does mirtazapine have a more rapid onset than SSRIs?

      JOURNAL OF CLINICAL PSYCHIATRY
    37. Clayton, AH; McGarvey, EL; Abouesh, AI; Pinkerton, RC
      Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction

      JOURNAL OF CLINICAL PSYCHIATRY
    38. Stahl, SM; Nierenberg, AA; Gorman, JM
      Evidence of early onset of antidepressant effect in randomized controlled trials

      JOURNAL OF CLINICAL PSYCHIATRY
    39. Ballenger, JC
      Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    40. Pollack, MH
      Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission

      JOURNAL OF CLINICAL PSYCHIATRY
    41. Marangell, LB
      Switching antidepressants for treatment-resistant major depression

      JOURNAL OF CLINICAL PSYCHIATRY
    42. Thase, ME
      Methodology to measure onset of action

      JOURNAL OF CLINICAL PSYCHIATRY
    43. Nierenberg, AA
      Do some antidepressants work faster than others?

      JOURNAL OF CLINICAL PSYCHIATRY
    44. Pollack, MH
      Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    45. Doraiswamy, PM
      Contemporary management of comorbid anxiety and depression in geriatric patients

      JOURNAL OF CLINICAL PSYCHIATRY
    46. Davidson, JRT
      Pharmacotherapy of generalized anxiety disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    47. Shoaf, TL; Emslie, GJ; Mayes, TL
      Childhood depression: Diagnosis and treatment strategies in general pediatrics

      PEDIATRIC ANNALS
    48. Shah, R; Uren, Z; Baker, A; Majeed, A
      Deaths from antidepressants in England and Wales 1993-1997: analysis of a new national database

      PSYCHOLOGICAL MEDICINE
    49. Rogoz, Z; Skuza, G; Dlaboga, D; Maj, J; Dziedzicka-Wasylewska, M
      Effect of repeated treatment with tianeptine and fluoxetine on the centralalpha(1)-adrenergic system

      NEUROPHARMACOLOGY
    50. Linden, M; Ludewig, K; Munz, T
      Depressive disorders and antidepressive therapy in outpatient and inpatient psychiatric treatment

      NERVENARZT
    51. Wikell, C; Hjorth, S; Apelqvist, G; Kullingsjo, J; Lundmark, J; Bergqvist, PBF; Bengtsson, F
      Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    52. Millan, MJ; Gobert, A; Lejeune, F; Newman-Tancredi, A; Rivet, JM; Auclair, A; Peglion, JL
      S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    53. Fanali, S; Rudaz, S; Veuthey, JL; Desiderio, C
      Use of vancomycin silica stationary phase in packed capillary electrochromatography II. Enantiomer separation of venlafaxine and O-desmethylvenlafaxine in human plasma

      JOURNAL OF CHROMATOGRAPHY A
    54. Versiani, M
      The selective noradrenaline re-uptake inhibitor reboxetine has an early onset of antidepressant action

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    55. Paton, C
      Survey of new antidepressants in secondary care

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    56. Balfour, JAB; Jarvis, B
      Venlafaxine extended-release - A review of its clinical potential in the management of generalised anxiety disorder

      CNS DRUGS
    57. Freeman, H; Arikian, S; Lenox-Smith, A
      Pharmacoeconomic analysis of antidepressants for major depressive disorderin the United Kingdom

      PHARMACOECONOMICS
    58. Bernardo, M; Navarro, V; Salva, J; Arrufat, FJ; Baeza, I
      Seizure activity and safety in combined treatment with venlafaxine and ECT: A pilot study

      JOURNAL OF ECT
    59. Ereshefsky, L; Dugan, D
      Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: Focus on venlafaxine

      DEPRESSION AND ANXIETY
    60. Kienke, AS; Rosenbaum, JF
      Efficacy of venlafaxine in the treatment of severe depression

      DEPRESSION AND ANXIETY
    61. Thase, ME; Friedman, ES; Howland, RH
      Venlafaxine and treatment-resistant depression

      DEPRESSION AND ANXIETY
    62. Gorman, JM; Papp, LA
      Efficacy of venlafaxine in mixed depression-anxiety states

      DEPRESSION AND ANXIETY
    63. Weller, EB; Weller, RA; Davis, GP
      Use of venlafaxine in children and adolescents: A review of current literature

      DEPRESSION AND ANXIETY
    64. Ninan, PT
      Use of venlafaxine in other psychiatric disorders

      DEPRESSION AND ANXIETY
    65. Schlienger, RG; Klink, MH; Eggenberger, C; Drewe, J
      Seizures associated with therapeutic doses of venlafaxine and trimipramine

      ANNALS OF PHARMACOTHERAPY
    66. Hard, GC
      Short-term adverse effects in humans of ingested mineral oils, their additives and possible contaminants - A review

      HUMAN & EXPERIMENTAL TOXICOLOGY
    67. Nathan, PJ; Sitaram, C; Stough, C; Silberstein, RB; Sali, A
      Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor

      BEHAVIOURAL PHARMACOLOGY
    68. Szabadi, E; Bradshaw, CM
      Mechanisms of action of reboxetine

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    69. Verma, S; Gallagher, RM
      Evaluating and treating co-morbid pain and depression

      INTERNATIONAL REVIEW OF PSYCHIATRY
    70. Sarko, J
      Antidepressants, old and new - A review of their adverse effects and toxicity in overdose

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    71. Rudaz, S; Stella, C; Balant-Gorgia, AE; Fanali, S; Veuthey, JL
      Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in clinical samples by capillary electrophoresis using charged cyclodextrins

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    72. Apelqvist, G; Wikell, C; Carlsson, B; Hjorth, S; Bergqvist, PBF; Ahlner, J; Bengtsson, F
      Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy

      CLINICAL NEUROPHARMACOLOGY
    73. Cordova, S; Lee, R
      Fixed, dilated pupils in the ICU: Another recoverable cause

      ANAESTHESIA AND INTENSIVE CARE
    74. Parikh, C
      Antidepressants in the elderly: challenges for study design and their interpretation

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    75. Maj, J; Rogoz, Z; Margas, W; Kata, M; Dziedzicka-Wasylewska, M
      The effect of repeated treatment with pramipexole on the central dopamine D-3 system

      JOURNAL OF NEURAL TRANSMISSION
    76. Harkin, A; Nally, R; Kelly, JP; Leonard, BE
      Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta 1-adrenergic receptors in an animal model of depression

      JOURNAL OF NEURAL TRANSMISSION
    77. Sitsen, JMA; Voortman, G; Timmer, CJ
      Pharmacokinetics of mirtazapine and lithium in healthy male subjects

      JOURNAL OF PSYCHOPHARMACOLOGY
    78. Gentil, V; Kerr-Correa, F; Moreno, R; Busnello, ED; de Campos, JA; Juruena, MF; Lafer, B; Moreno, DH; Rosa, LDR; Tiosso, A; Benedictis, E
      Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia

      JOURNAL OF PSYCHOPHARMACOLOGY
    79. Ballus, C; Quiros, G; de Flores, T; de la Torre, J; Palao, D; Rojo, L; Gutierrez, M; Casais, L; Riesgo, Y
      The efficacy and tolerability of venlafaxine and paroxetine in outpatientswith depressive disorder or dysthymia

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    80. Pinzani, V; Ginies, E; Robert, L; Peyriere, H; Abbar, M; Blayac, JP
      Venlafaxine withdrawal syndrome: report of six cases and literature review.

      REVUE DE MEDECINE INTERNE
    81. Amsterdam, JD; Garcia-Espana, F
      Venlafaxine monotherapy in women with bipolar II and unipolar major depression

      JOURNAL OF AFFECTIVE DISORDERS
    82. Argyropoulos, SV; Sandford, JJ; Nutt, DJ
      The psychobiology of anxiolytic drugs - Part 2: pharmacological treatmentsof anxiety

      PHARMACOLOGY & THERAPEUTICS
    83. Veefkind, AH; Hafmans, PMJ; Hoencamp, E
      Venlafaxine serum levels and CYP2D6 genotype

      THERAPEUTIC DRUG MONITORING
    84. Benkert, O; Szegedi, A; Kohnen, R
      Mirtazapine compared with paroxetine in major depression

      JOURNAL OF CLINICAL PSYCHIATRY
    85. Terao, T; Ikemura, N
      SSRI-TCA combination in the treatment of resistant depression

      JOURNAL OF CLINICAL PSYCHIATRY
    86. Blass, DM; Pearson, VE
      SIADH with multiple antidepressants in a geriatric patient

      JOURNAL OF CLINICAL PSYCHIATRY
    87. Sullivan, EM; Griffiths, RI; Frank, RG; Strauss, MJ; Herbert, RJ; Clouse, J; Goldman, HH
      One-year costs of second-line therapies for depression

      JOURNAL OF CLINICAL PSYCHIATRY
    88. Fava, M
      Management of nonresponse and intolerance: Switching strategies

      JOURNAL OF CLINICAL PSYCHIATRY
    89. Thase, ME
      Treatment issues related to sleep and depression

      JOURNAL OF CLINICAL PSYCHIATRY
    90. Gorman, JM; Sullivan, G
      Noradrenergic approaches to antidepressant therapy

      JOURNAL OF CLINICAL PSYCHIATRY
    91. Kent, JM
      SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

      LANCET
    92. Connor, TJ; Kelliher, P; Shen, Y; Harkin, A; Kelly, JP; Leonard, BE
      Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    93. Keck, PE; Arnold, LM
      The serotonin syndrome

      PSYCHIATRIC ANNALS
    94. Glick, RL
      Initiation of antidepressant medications in the emergency setting

      PSYCHIATRIC ANNALS
    95. Sadeg, N; Richecoeur, J; Dumontet, M
      Overdose with venlafaxine associated with benzodiazepines, lithium and alimemazine

      THERAPIE
    96. Perry, NK
      Venlafaxine-induced serotonin syndrome with relapse following amitriptyline

      POSTGRADUATE MEDICAL JOURNAL
    97. Hegerl, U; Moller, HJ
      Pharmacotherapy of depression in oldage

      NERVENARZT
    98. Mason, PJ; Morris, VA; Balcezak, TJ
      Serotonin syndrome - Presentation of 2 cases and review of the literature

      MEDICINE
    99. Hickie, IB
      An approach to managing depression in general practice

      MEDICAL JOURNAL OF AUSTRALIA
    100. Kunsman, GW; Kunsman, CM; Presses, CL; Garavaglia, JC; Farley, NJ
      A mixed-drug intoxication involving venlafaxine and verapamil

      JOURNAL OF FORENSIC SCIENCES


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 19:15:32